W. P. Carey completed a US$468 million sale-leaseback transaction involving four pharmaceutical R&D and manufacturing campuses leased to Apotex Pharmaceutical Holdings Inc. This portfolio, representing a major portion of Apotex’s global operations, spans 11 properties across 2.3 million square feet in Toronto's industrial submarkets. The deal includes a 20-year, triple-net master lease with fixed rent escalations, supporting Apotex's operations while enabling Apotex's new private equity owner, SK Capital, to finance part of its buyout.

McMillan LLP provided legal counsel to W. P. Carey, with Brett Stewart and David Dudkiewicz leading the team to advise on corporate, real estate, and tax aspects of the transaction